Katerina Machova Polakova

12PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 26, 2025
Venetoclax in combination with ponatinib for the treatment of asciminib-resistant chronic myeloid leukemia.

Nikola Curik, Adam Laznicka, Jitka Krizkova

|Apr 28, 2025
Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemia.

Jitka Krizkova, Vaclava Polivkova, Adam Laznicka

|Jan 28, 2025
Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia.

Jiří Mayer, Petra Čičátková, Lenka Kováčová

|Apr 13, 2024
Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations.

Nikola Curik, Adam Laznicka, Vaclava Polivkova

|Feb 05, 2024
Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia.

Adela Benesova, Sara De Santis, Vaclava Polivkova

|Dec 21, 2023
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib.

Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova

Pageof 2

Frequent Collaborators

4 joint publications

Nicholas C P Cross

4 joint publications

Andreas Hochhaus

4 joint publications

Thomas Ernst

3 joint publications

Simona Soverini